Similar to the effect seen when culturing soft ECMs, treatment with JAK inhibitor I prevented MYC expression in cells cultured on stiff ECMs (Figure 5G), suggesting that stiff ECMs may activate the JAK-MYC-ATF5 axis in cancer cells. The gene discussed is ATF5; the disease is cancer.